UPDATE : Monday, October 21, 2019
상단여백
Helixmith unveils results for neuromuscular disease treatment
Helixmith has published a study that confirmed the efficacy of AV6-H’s, a g...
by Lee Han-soo  |  2019-08-02 17:52
라인
‘MSD Korea playing tricks to maintain monitoring on salespersons’
MSD Korea’s labor and management are again in dispute over the so-called “s...
by Kim Yun-mi  |  2019-08-02 15:48
라인
Conflict erupts between employees of Takeda, Shire during merger
Takeda Pharmaceutical Korea’s labor union said Takeda employees faced unfai...
by Kim Yun-mi  |  2019-08-02 14:23
라인
Sillajen likely to scrap global P3 trials for Pexa-Vec
Sillajen is in danger of aborting its phase 3 clinical trial for Pexa-Vec (...
by Lee Han-soo  |  2019-08-02 10:29
라인
KAIST-Hanyang University team presents new anticancer principle
Researchers at Korea Advanced Institute of Science & Technology (KAIST) and...
by Lee Han-soo  |  2019-08-01 17:30
라인
Health ministry to reimburse Novartis’ Revolade treating severe aplastic anemia
Novartis Korea’s Revolade (ingredient: eltrombopag) will receive reimbursem...
by Lee Han-soo  |  2019-08-01 13:36
라인
New weight loss drug Qsymia wins local approval
The local drug regulator has approved a new obesity treatment, Qsymia Cap. ...
by Lee Hye-seon  |  2019-08-01 10:57
라인
‘Hanmi’s Carnitil improves cognitive function in patients’
Hanmi Pharmaceutical said that it has presented the phase 4 clinical trial ...
by Lee Han-soo  |  2019-07-31 17:05
라인
Hanall marks record sales in Q2
Hanall Biopharma said that it registered record-breaking sales and operatin...
by Lee Han-soo  |  2019-07-31 17:00
라인
Novartis fails to expand heart failure drug Entresto’s indication
Novartis said its phase-3 Paragon-HF trial on heart failure treatment Entre...
by Kim Yun-mi  |  2019-07-31 14:26
라인
Hanmi marks ₩270.4 billion in Q2 sales
Hanmi Pharmaceutical said Tuesday that it recorded sales of 270.4 billion w...
by Lee Han-soo  |  2019-07-30 17:26
라인
Kolmar Korea boosts beauty, health biz through acquisitions
Kolmar Korea Holdings, having units in cosmetics, pharmaceuticals, and heal...
by Park Gi-taek  |  2019-07-30 14:43
라인
GC’s Chinese partner applies for Hunter syndrome drug’s sales approval
GC said that CANBridge Pharmaceuticals, its Chinese partner, has applied fo...
by Lee Han-soo  |  2019-07-30 10:49
라인
‘FDA likely to OK 11 blockbuster candidates in August’
The U.S. Food and Drug Administration (FDA) will likely approve 11 innovati...
by Kim Yun-mi  |  2019-07-29 16:55
라인
Top-30 makers produce more than half of drugs
Drug output by 30 largest pharmaceutical companies accounted for 54 percent...
by Lee Hye-seon  |  2019-07-29 16:38
라인
Takeda’s Zejula poised to change local ovarian cancer treatment market
Takeda’s Zejula (ingredient: niraparib) became eligible for an insurance be...
by Kim Yun-mi  |  2019-07-29 12:04
라인
Court extends ‘temporary suspension’ of order to cancel Invossa trials
A local court has decided to temporarily suspend the legal effect of an adm...
by Jeong Sae-im  |  2019-07-26 17:50
라인
SNUBH professor is 1st Asian keynoter at international Alzheimer meet
Professor Kim Sang-yun of Seoul National University Bundang Hospital has be...
by Lee Han-soo  |  2019-07-26 16:08
라인
‘Kolon Life Science to start following up on Invossa-treated patients’
Kolon Life Science will conduct the first test on patients who received Inv...
by Lee Han-soo  |  2019-07-26 12:21
라인
JW Creagene wins US patent for making dendritic cell treatment
JW Creagene said Thursday that it has obtained a patent for its source tech...
by Lee Han-soo  |  2019-07-25 16:39
여백
여백
여백
Back to Top